Skip to main navigation

1.866.648.2767

info@tabularasahealthcare.com

Investors
mobilemenu

Investors - Investor News

Investors - Investor News

Keyword Search

Year

TRHC and Equiscript Launch an Advanced Medication Adherence Reporting and Analytics Program

16 Jun 2020

Regence and TRHC partner on COVID-19 virtual clinical trial to assess proposed treatment risks

09 Jun 2020

TRHC’s MedWise Risk Score™ Reduces the Odds of Adverse Drug Events, Keeping Patients Safer

27 May 2020

TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource

19 May 2020

TRHC and ASCP Sign Letter of Intent to offer MedWise™ to Consultant Pharmacists

11 May 2020

Tabula Rasa HealthCare Reports First Quarter 2020 Results

07 May 2020

TRHC and Speed Script Expand Partnership for Clinical Documentation

04 May 2020

TRHC Launches First Large Simulation Study to Assess Adverse Drug Events with proposed COVID-19 Treatments

29 Apr 2020

Tabula Rasa HealthCare to Release First Quarter 2020 Operating Results May 7, 2020

23 Apr 2020

Tabula Rasa HealthCare and Strategic Solutions Network Partner on a Free COVID-19 Medication Safety Webinar

23 Apr 2020

Pagination

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Page 11
Page 12
Page 13
…
Next page
Last page

Investor Relations

Overview
Investor News
Events & Presentations
Stock Information
Corporate Governance
Financial Information
Investor Resources

IR CONTACT

Frank Sparacino

(866) 648-2767

fsparacino@trhc.com

RECEIVE E-MAIL ALERTS

Stay up to date on the latest Tabula Rasa HealthCare (TRHC) news.

Contact Us

1.866.648.2767

info@tabularasahealthcare.com

228 Strawbridge Drive
Moorestown NJ 08057

Careers

We are looking for individuals that can grow with our company. We offer a comprehensive benefits package, along with competitive compensation. Learn more today by clicking below.

Learn more >

©2021 Tabula Rasa Healthcare Legal | Privacy | Contact Us